These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21900200)

  • 1. Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.
    Lucioni M; Novara F; Fiandrino G; Riboni R; Fanoni D; Arra M; Venegoni L; Nicola M; Dallera E; Arcaini L; Onida F; Vezzoli P; Travaglino E; Boveri E; Zuffardi O; Paulli M; Berti E
    Blood; 2011 Oct; 118(17):4591-4. PubMed ID: 21900200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrowing down the common deleted region of 5q to 6.0 Mb in blastic plasmacytoid dendritic cell neoplasms.
    Fu Y; Fesler M; Mahmud G; Bernreuter K; Jia D; Batanian JR
    Cancer Genet; 2013; 206(7-8):293-8. PubMed ID: 24042168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome analysis uncovers recurrent IKZF1 inactivation and aberrant cell adhesion in blastic plasmacytoid dendritic cell neoplasm.
    Bastidas Torres AN; Cats D; Mei H; Fanoni D; Gliozzo J; Corti L; Paulli M; Vermeer MH; Willemze R; Berti E; Tensen CP
    Genes Chromosomes Cancer; 2020 May; 59(5):295-308. PubMed ID: 31846142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of the cell-cycle inhibitors p27(KIP1) and p16(INK4a) are frequent in blastic plasmacytoid dendritic cell neoplasms.
    Wiesner T; Obenauf AC; Cota C; Fried I; Speicher MR; Cerroni L
    J Invest Dermatol; 2010 Apr; 130(4):1152-7. PubMed ID: 19924135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events.
    Tang Z; Li Y; Wang W; Yin CC; Tang G; Aung PP; Hu S; Lu X; Toruner GA; Medeiros LJ; Khoury JD
    Leuk Res; 2018 Oct; 73():86-94. PubMed ID: 30248580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent 8q24 rearrangement in blastic plasmacytoid dendritic cell neoplasm: association with immunoblastoid cytomorphology, MYC expression, and drug response.
    Sakamoto K; Katayama R; Asaka R; Sakata S; Baba S; Nakasone H; Koike S; Tsuyama N; Dobashi A; Sasaki M; Ichinohasama R; Takakuwa E; Yamazaki R; Takizawa J; Maeda T; Narita M; Izutsu K; Kanda Y; Ohshima K; Takeuchi K
    Leukemia; 2018 Dec; 32(12):2590-2603. PubMed ID: 29795241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
    Cheng W; Yu TT; Tang AP; He Young K; Yu L
    Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
    Lim MS; Lemmert K; Enjeti A
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-interferon secreting blastic plasmacytoid dendritic cells neoplasm: a case report with histological, molecular genetics and long-term tumor cells culture studies.
    Petrella T; Hervé G; Bonnotte B; Girodon F; Carlson JA; Bour JB; Lebon P; Mugneret F; Callier P
    Am J Dermatopathol; 2012 Aug; 34(6):626-31. PubMed ID: 22534638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
    Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
    Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted ultra-deep sequencing reveals recurrent and mutually exclusive mutations of cancer genes in blastic plasmacytoid dendritic cell neoplasm.
    Stenzinger A; Endris V; Pfarr N; Andrulis M; Jöhrens K; Klauschen F; Siebolts U; Wolf T; Koch PS; Schulz M; Hartschuh W; Goerdt S; Lennerz JK; Wickenhauser C; Klapper W; Anagnostopoulos I; Weichert W
    Oncotarget; 2014 Aug; 5(15):6404-13. PubMed ID: 25115387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.
    Julia F; Petrella T; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dereure O; Wetterwald M; d'Incan M; Grange F; Cornillon J; Tertian G; Maubec E; Saiag P; Barete S; Templier I; Aubin F; Dalle S
    Br J Dermatol; 2013 Sep; 169(3):579-86. PubMed ID: 23646868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KMT2A (MLL)-MLLT1 rearrangement in blastic plasmacytoid dendritic cell neoplasm.
    Yang N; Huh J; Chung WS; Cho MS; Ryu KH; Chung HS
    Cancer Genet; 2015 Sep; 208(9):464-7. PubMed ID: 26164398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case report: Blastic plasmacytoid dendritic cell neoplasm is misdiagnosed as breast infiltrating ductal carcinoma.
    Chen KC; Su TC; Chen DR; Liou JH
    Int J Surg Pathol; 2015 Feb; 23(1):84-8. PubMed ID: 25297609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review.
    Kim MJ; Nasr A; Kabir B; de Nanassy J; Tang K; Menzies-Toman D; Johnston D; El Demellawy D
    J Pediatr Hematol Oncol; 2017 Oct; 39(7):528-537. PubMed ID: 28906324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blastic plasmacytoid dendritic cell neoplasm.
    Lim D; Goodman H; Rademaker M; Lamont D; Yung A
    Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
    Patel JL; Shetty S; Salama ME
    Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review.
    Shi Y; Wang E
    Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
    Zhang X; Sun J; Yang M; Wang L; Jin J
    Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report.
    Dang X; Zhou D; Meng L; Bi L
    J Int Med Res; 2021 Feb; 49(2):300060520982667. PubMed ID: 33530792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.